Rigrodsky & Long, P.A. Announces Investigation of eResearchTechnology, Inc. Takeover
Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of eResearchTechnology, Inc. (NasdaqGS: ERT) (“eResearch” or “the Company”) concerning possible breaches of fiduciary duty and other violations of law related to Genstar Capital LLC's (“Genstar Capital”) buyout of the public shareholders of the Company at $8.00 per share.
Click here to learn more: http://www.rigrodskylong.com/investigations/eresearchtechnology-inc-ert.
The investigation concerns whether eResearch's board of directors failed to adequately shop the Company and to get the best price possible for eResearch's shareholders before entering into the buyout agreement with Genstar Capital.
Under the terms of the buyout agreement, the shareholders of eResearch will receive $8.00 per share in cash for each share of the Company they own. However, according to Yahoo! Finance, at least one analyst has set a price target for eResearch stock at $11.00.
If you own the common stock of eResearch and purchased your shares before April 10, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Scott J. Farrell, Esquire of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to firstname.lastname@example.org, or at: http://www.rigrodskylong.com/investigations/eresearch-inc-ert.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.